Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,073,006
  • Shares Outstanding, K 49,342
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 580 M
  • EBITDA $ 1,149 M
  • 60-Month Beta 1.61
  • Price/Sales 2.17
  • Price/Cash Flow 8.06
  • Price/Book 2.75

Options Overview Details

View History
  • Implied Volatility 54.82% (-1.46%)
  • Historical Volatility 51.66%
  • IV Percentile 82%
  • IV Rank 53.94%
  • IV High 74.13% on 04/21/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 26) 19.20 (10.44%)
  • Put/Call Vol Ratio 0.36
  • Today's Volume 80
  • Volume Avg (30-Day) 92
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 4,425
  • Open Int (30-Day) 5,465
  • Expected Range 164.68 to 203.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.96
  • Number of Estimates 8
  • High Estimate $2.05
  • Low Estimate $1.91
  • Prior Year $2.34
  • Growth Rate Est. (year over year) -16.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.63 +22.89%
on 03/18/26
185.61 -0.93%
on 04/17/26
+30.17 (+19.63%)
since 03/17/26
3-Month
146.33 +25.66%
on 02/18/26
228.39 -19.49%
on 01/22/26
-35.82 (-16.30%)
since 01/16/26
52-Week
99.80 +84.25%
on 04/21/25
228.88 -19.66%
on 01/13/26
+77.83 (+73.39%)
since 04/17/25

Most Recent Stories

More News
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

RGEN : 131.21 (+3.24%)
BAX : 18.71 (+3.14%)
CRL : 183.88 (+3.92%)
NVST : 27.84 (+3.34%)
SGRY : 14.00 (+4.24%)
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2026 financial results on Thursday, May 7 th , before the market opens. A conference call has been scheduled...

CRL : 183.88 (+3.92%)
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health,...

CRL : 183.88 (+3.92%)
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

FTRE : 10.38 (+2.87%)
GH : 90.36 (+5.44%)
OGN : 9.76 (+4.61%)
CRL : 183.88 (+3.92%)
QDEL : 12.71 (+0.20%)
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX

NYSE issues a pre-market daily advisory direct from the trading floor.

ICE : 161.24 (-1.53%)
CRL : 183.88 (+3.92%)
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds

1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds

HP : 33.64 (-3.72%)
CRL : 183.88 (+3.92%)
VNT : 37.30 (+2.28%)
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 134.50 (+1.34%)
EVH : 2.84 (-5.02%)
RGEN : 131.21 (+3.24%)
CRL : 183.88 (+3.92%)
RDNT : 60.39 (+0.50%)
1 Value Stock on Our Buy List and 2 We Turn Down

1 Value Stock on Our Buy List and 2 We Turn Down

MU : 455.07 (-0.47%)
JLL : 346.43 (+3.64%)
CRL : 183.88 (+3.92%)
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

XLV : 148.80 (+1.49%)
CRL : 183.88 (+3.92%)
IQV : 176.46 (+2.62%)
3 Reasons CRL is Risky and 1 Stock to Buy Instead

3 Reasons CRL is Risky and 1 Stock to Buy Instead

CRL : 183.88 (+3.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 193.18
2nd Resistance Point 189.40
1st Resistance Point 186.64
Last Price 183.88
1st Support Level 180.09
2nd Support Level 176.31
3rd Support Level 173.55

See More

52-Week High 228.88
Last Price 183.88
Fibonacci 61.8% 179.57
Fibonacci 50% 164.34
Fibonacci 38.2% 149.11
52-Week Low 99.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.